of the individual GWAS within each sample type (ALSPAC+FT12 and COGA+IASPSAD) and used these meta-analysis summary statistics to create additional polygenic scores in the two samples of the other type. Each of the four study samples was therefore used once as a discovery GWAS sample and four times as a validation sample for testing the value of the polygenic scores in predicting alcohol problems.